Warranty and Technical Support Services (Post-Installation)

The contract outlines the provision of manufacturer-backed technical support, troubleshooting, and repair services for equipment deployed in a regulated biopharmaceutical environment, with a required duration of at least one year following acceptance. These services must comply with the stringent quality and regulatory standards typical of the biopharma sector, ensuring uninterrupted operation and full traceability of maintenance activities. The scope includes prompt resolution of technical issues, replacement of faulty components, and documentation of all interventions to meet compliance requirements. The contract is classified as a subcontract under NAICS code 541715 and is issued by the FDA Office of Acquisition and Grant Services under the U.S. Department of Health and Human Services. The place of performance is designated as Irvine, California, with a response deadline of July 8, 2026, and a posted date of July 2, 2026. No set-aside type is specified, and while no point of contact is listed, the opportunity is accessible via the SAM.gov platform. Participation requires proven experience in delivering supported technical services within highly regulated environments, emphasizing reliability, regulatory alignment, and timely response capabilities.